A Single-Center, Open Label Pilot Study Examining The Use Of Duloxetine In The Prevention Of Episodic Migraine.
Latest Information Update: 08 Jul 2014
At a glance
- Drugs Duloxetine (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 19 May 2011 Planned end date changed from 1 Mar 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 27 Oct 2010 Planned end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 27 Oct 2010 Actual initiation date (Aug 2007) added as reported by ClinicalTrials.gov.